Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Nathanson

Showing results (251-260 of 528) with videos related to

Pageof 53
Sort By:
Oncotarget|May 19, 2016
Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutationsStephanie Jean, Jiaqi Li, Dionyssios Katsaros, et al.
Molecular Cancer Research : MCR|May 14, 2021
Mastermind Like Transcriptional Coactivator 3 (MAML3) Drives Neuroendocrine Tumor ProgressionNathaniel Alzofon, Katrina Koc, Kristin Panwell, et al.
Journal of Genetic Counseling|October 10, 2025
Assessment of barriers to pancreatic cancer surveillance in high-risk individualsGrace G Snyder, Daniel Clay, Sara Karley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testingC F Rowlands, S Allen, J Balmaña, et al.
The American Journal of Gastroenterology|September 24, 2020
Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni SyndromeBryson W Katona, Jacquelyn Powers, Danielle B McKenna, et al.
JCO Precision Oncology|September 13, 2019
Identification and Confirmation of Potentially Actionable Germline Mutations in Tumor-Only Genomic SequencingDana Farengo Clark, Kara N Maxwell, Jacquelyn Powers, et al.
Clinical Epigenetics|June 9, 2015
MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603Liza C Villaruz, Grace Huang, Marjorie Romkes, et al.
Cancer Cell|December 9, 2008
HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinomaJohn D Gordan, Priti Lal, Vijay R Dondeti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 10, 2020
Real-world integration of genomic data into the electronic health record: the PennChart Genomics InitiativeKelsey S Lau-Min, Stephanie Byers Asher, Jessica Chen, et al.
JAMA Oncology|May 27, 2021
Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United StatesSusan M Domchek, Song Yao, Fei Chen, et al.
Pageof 53

Showing results (251-260 of 528) with videos related to

Sort By:
Pageof 53
Oncotarget|May 19, 2016
Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutationsStephanie Jean, Jiaqi Li, Dionyssios Katsaros, et al.
Molecular Cancer Research : MCR|May 14, 2021
Mastermind Like Transcriptional Coactivator 3 (MAML3) Drives Neuroendocrine Tumor ProgressionNathaniel Alzofon, Katrina Koc, Kristin Panwell, et al.
Journal of Genetic Counseling|October 10, 2025
Assessment of barriers to pancreatic cancer surveillance in high-risk individualsGrace G Snyder, Daniel Clay, Sara Karley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2024
Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testingC F Rowlands, S Allen, J Balmaña, et al.
The American Journal of Gastroenterology|September 24, 2020
Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni SyndromeBryson W Katona, Jacquelyn Powers, Danielle B McKenna, et al.
JCO Precision Oncology|September 13, 2019
Identification and Confirmation of Potentially Actionable Germline Mutations in Tumor-Only Genomic SequencingDana Farengo Clark, Kara N Maxwell, Jacquelyn Powers, et al.
Clinical Epigenetics|June 9, 2015
MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603Liza C Villaruz, Grace Huang, Marjorie Romkes, et al.
Cancer Cell|December 9, 2008
HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinomaJohn D Gordan, Priti Lal, Vijay R Dondeti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 10, 2020
Real-world integration of genomic data into the electronic health record: the PennChart Genomics InitiativeKelsey S Lau-Min, Stephanie Byers Asher, Jessica Chen, et al.
JAMA Oncology|May 27, 2021
Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United StatesSusan M Domchek, Song Yao, Fei Chen, et al.
Pageof 53